Search

everythinglearnresearchcommunity

for

Search:↓

CDP is crucial for lung and hair follicle cell development.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Prolactin slows down hair growth in mice.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

GLI2 increases follistatin production in human skin cells.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Scientists created a long-lasting stem cell line from human hair that can turn into different skin and hair cell types.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Immune cells affect hair growth and could lead to new hair loss treatments.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Telomere damage affects skin and hair follicle stem cells by messing up important growth signals.